Skip to main content

OmniAb, Inc. (OABI)

Sector
Life Sciences Tools & Services
Last price
$5.05
As of

Kresmion compiles this page from OABI's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

OmniAb, Inc. (OABI): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q3 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-10-30.

As of . Source: SEC EDGAR filings for OABI. Method and limitations.

COMPANY DOSSIER

See the full OABI dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for OABI on one page. Preview it with sample data, then open it live with a free account.

Preview the OABI dossier

Active events for OABI

FREE, NO ACCOUNT

Every event on OABI, as it fires

You are seeing 5 of 7 events recorded on OABI since 2026-06-03.

The five above landed across 4 days. The other 2 were recorded on 1 other days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

OABI positions held by the managers we follow (2026Q3)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported value
RENAISSANCE TECHNOLOGIES LLC FundCUSIP 68218J103 · 2026Q3$3.7M0.01%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, OABI

More data on OABI

OABI against its peers

OABI's operating margin of -369.5% ranks in the 6th percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.

MetricOABIPeer medianPercentilen
Revenue FY18.7M USD1.2B USD625
Gross marginn/a55.5%n/a17
Operating margin-369.5%-9.5%623
Net margin-347.0%-6.8%625
Return on equity-24.3%-7.5%3824
P / En/a42.4xn/a9
1 year196.4%22.5%9025

Peers (25): CTKB, MLAB, DNA, PACB, MRVI, FTRE, ABCL, MXCT, CDXS, ADPT, SHC, SEER, TXG, BRKR, AVTR, RGEN, TECH, TEM, CRL, MEDP, ILMN, MTD, IQV, A, WAT. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (OABI: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in OABI on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on OABI in the last 180 days.

Upstream: SEC EDGAR filings for OABI

Kresmion, "OmniAb, Inc. (OABI) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/OABI. Upstream data: SEC EDGAR filings for OABI.

Link to this data (HTML):

<a href="https://kresmion.com/research/OABI">OmniAb, Inc. (OABI) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow OABI on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to OABI for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the OABI dossier
Share

The OABI intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.